| AD | Alzheimer’s Disease |
| PD | Parkinson’s Disease |
| MS | Multiple Sclerosis |
| ALS | Amyotrophic Lateral Sclerosis |
| hGMSCs | human Gingival Mesenchymal Stem Cells |
| MOR | Moringin |
| CBD | Cannabidiol |
| IL-10 | Interleukin 10 |
| IL-1 | Interleukin 1 |
| IL-6 | Interleukin-6 |
| TNF-α | Tumor Necrosis Factor alpha |
| IL6R | IL-6 Receptor |
| TGF-β | Transform Growth Factor beta |
| hGMSCs-MOR | hGMSCs treated with MOR |
| hGMSCs-CBD | hGMSCs treated with CBD |
| RT-PCR | reverse transcription polymerase chain reaction |
| CLSM | Confocal Laser Scanning Microscopy |
| hGMSCs-CTRL | hGMSCs untreated |
| TNFR1 | TNF receptor 1 |
| RIPK1 | Receptor Interacting Protein Kinase 1 |
| IKK | IκB kinase |
| IL1R1 | IL-1 receptor type I |
| TIR | Toll-IL-1-Receptor |
| MAPK | Mitogen-Activated Protein Kinase |
| MAP3K3 | Mitogen-Activated Protein Kinase Kinase Kinase 3 |
| JAKs | Janus kinases |
| TGFβR1 | TGFβ Receptor type 1 |
| TGFβR2 | TGFβ Receptor type 2 |
| PP1 | Protein Phosphatase 1 |
| PBS | Phosphate Buffered Saline |
| MTT | 3-(4,5-dimethylthiazolyl-2)-2,5-diphenyltetrazoliumbromide |